Table 1. Changes in Phosphorylated RLC Proportions in uterine myocytes.
| % of total RLC | ||||
| N | 0pRLC | 1pRLC | 2pRLC | |
| Untreated | 12 | 47±4 | 36±2 | 16±3 |
| g-H (1 µM) | 5 | 86±2* | 7±2** | 6±2*** |
| OT (100 nM) | 7 | 10±2* | 54±11 | 36±10*** |
| OT+g-H | 4 | 19±7* | 80±8** | 1±1*** |
| OT+ML7 (25 µM) | 4 | 20±8* | 66±4** | 14±6 |
| OT+ML7+g-H | 4 | 40±4 | 51±6** | 9±2 |
| Calp (0.5 mU/mL) | 8 | 29±6* | 34±4 | 38±8*** |
| Calp+g-H | 3 | 76±12* | 33±15 | 0±0*** |
| Calp+ML7 | 3 | 37±3 | 37±3 | 26±0 |
| Calp+ML7+g-H | 2 | 40±0 | 34±2 | 26±1 |
All data are shown as mean ± SEM.
*, **, and ***indicate significant differences (p<0.05) compared to 0pRLC, 1pRLC and 2pRLC in the untreated group, respectively.